PL37: Phase Ib data

A double-blind, U.K. Phase Ib trial in 76 healthy male volunteers showed that oral PL37 significantly reduced capsaicin-induced pain ratings on day 1 at 1-5 minutes and on day 5 at 5-15 minutes post-c...